As shown by Ahn et al., in a study of 125 CCA patients with tumoral PD-L1 positivity (at least 1% expression), those with at least 50% or more of PD-L1 expression had significantly higher overall response rate and disease control [58]. This evidence concerns the gene CD274 and cholangiocarcinoma.